Carbapenem derivatives
CA 2002551 C · Owner: Daiichi Pharmaceutical Co. Ltd. · Inventors: Takemura, Makoto; Hayano, Takeshi; Koda, Hiroko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Carbapenem derivatives of formula (I): (see fig. I), wherein (a) R1 is a hydrogen atom an alkyl group of, from 1 to 6 carbon atomsr a hydroxy-lower alkyl group or a protected hydroxy-lower alkyl group of from 1 to 6 carbon atoms in its alkyl moiety, (b) COOR2 is a carboxyl group, a carboxylate anion or a protected carboxyl group, (c) R3 is an alkyl group of from 1 to 6 carbon atoms and (d) R4 is a substituted or unsubstituted heterobicyclic group of formula (II):, (see fig. II) in which the partial structure, (see fig. III) is a 5- or 6-membered, saturated or unsaturated nitrogen-containing heterocycle containing 1 to 4 hetero atoms each selected from the group consisting of oxygen sulfur …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 8, 1989 and granted April 6, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 8, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 8, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.